Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.5215
+0.0186 (3.70%)
At close: Oct 2, 2026, 4:00 PM EDT
0.5211
-0.0004 (-0.08%)
After-hours: Oct 2, 2026, 7:55 PM EDT
Humacyte Employees
Humacyte had 184 employees as of December 31, 2025. The number of employees decreased by 36 or -16.36% compared to the previous year.
Employees
184
Change (1Y)
-36
Growth (1Y)
-16.36%
Revenue / Employee
$11,527
Profits / Employee
-$525,370
Market Cap
144.87M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 184 | -36 | -16.36% | 184 | 0 |
| Dec 31, 2024 | 220 | 35 | 18.92% | 218 | 2 |
| Dec 31, 2023 | 185 | 21 | 12.80% | 183 | 2 |
| Dec 31, 2022 | 164 | 18 | 12.33% | 164 | 0 |
| Dec 31, 2021 | 146 | - | - | 145 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Tonix Pharmaceuticals Holding | 142 |
| Voyager Therapeutics | 141 |
| Molecular Partners AG | 134 |
| Innate Pharma | 120 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 57 |
| PMV Pharmaceuticals | 54 |
HUMA News
- 5 days ago - Humacyte announces addition of Coward, Kuznik to board - TheFly
- 5 days ago - Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik - GlobeNewsWire
- 17 days ago - Humacyte Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 23 days ago - Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 24 days ago - Humacyte announces FDA extension of expiration dating period for Symvess - TheFly
- 24 days ago - Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months - GlobeNewsWire
- 4 weeks ago - Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA - Business Wire
- 5 weeks ago - Humacyte confirms plans for ATEV supplemental biologic license application - TheFly